Ischemic Infarction of Pituitary Apoplexy: A Retrospective Study of 46 Cases From a Single Tertiary Center

Objective Ischemic infarction of pituitary apoplexy (PA) is a rare type of pituitary apoplexy. This study aims to characterize ischemic PA via clinical presentations, imaging data, histopathological manifestations, and focus on the management and prognosis of the disease. Methods This study retrospectively identified 46 patients with ischemic PA confirmed using histopathology at a single institution from January 2013 to December 2020. The clinical presentations, imaging data, laboratory examination, management, and outcomes were collected. We then summarized the clinical presentations, imaging features, intraoperative findings, and histopathological manifestations, and compared the outcomes based on the timing of surgical intervention. Results Headache was the most common initial symptom (95.65%, 44/46), followed by visual disturbance (89.13%, 41/46), and nausea and vomiting (58.70%, 27/46). 91.3% of the patients had at least one pituitary dysfunction, with hypogonadism being the most common endocrine dysfunction (84.78%, 39/46). Cortisol dysfunction occurred in 24 (52.17%) patients and thyroid dysfunction occurred in 17 (36.96%). Typical rim enhancement and thickening of the sphenoid sinus on MRI were seen in 35 (85.37%) and 26 (56.52%) patients, respectively. Except for one patient with asymptomatic apoplexy, the remaining patients underwent early (≤ 1 week, 12 patients) and delayed (> 1 week, 33 patients) transsphenoidal surgery. Total tumor resection was achieved in 27 patients and subtotal tumor resection in 19 patients. At surgery, cottage cheese–like necrosis was observed in 50% (23/46) of the patients. At the last follow-up of 5.5 ± 2.7 years, 92.68% (38/41) of the patients had gained a significant improvement in visual disturbance regardless of surgical timing, and 65% of the patients were still receiving long-term hormone replacement therapy. Conclusion Patients with ischemic PA can be accurately diagnosed by typical imaging characteristics preoperatively. The timing of surgical intervention does not significantly affect the resolution of neurological and endocrinological dysfunctions. Preoperative endocrine dysfunctions are common and usually appear to be poor after surgical intervention.

[1]  L. Zhong,et al.  Clinical Features, Magnetic Resonance Imaging, and Treatment Experience of 20 Patients with Lymphocytic Hypophysitis in a Single Center. , 2019, World neurosurgery.

[2]  Lu Gao,et al.  Coagulative necrotic pituitary adenoma apoplexy: A retrospective study of 21 cases from a large pituitary center in China , 2018, Pituitary.

[3]  N. Gupta,et al.  Clinical and imaging features of pituitary apoplexy and role of imaging in differentiation of clinical mimics. , 2018, Quantitative imaging in medicine and surgery.

[4]  S. Kunwar,et al.  Surgical intervention for pituitary apoplexy: an analysis of functional outcomes. , 2017, Journal of neurosurgery.

[5]  M. Vaphiades Pituitary Ring Sign Plus Sphenoid Sinus Mucosal Thickening: Neuroimaging Signs of Pituitary Apoplexy , 2017, Neuro-ophthalmology.

[6]  K. Karabatsou,et al.  Sphenoid sinus mucosal thickening in the acute phase of pituitary apoplexy , 2017, Pituitary.

[7]  S. Mugikura,et al.  Ischemic pituitary adenoma apoplexy—Clinical appearance and prognosis after surgical intervention , 2016, Clinical Neurology and Neurosurgery.

[8]  K. Gnanalingham,et al.  Pituitary apoplexy – bespoke patient management allows good clinical outcome , 2016, Clinical endocrinology.

[9]  F. Meyer,et al.  Management and outcomes of pituitary apoplexy. , 2015, Journal of neurosurgery.

[10]  Lin Zhao,et al.  Clinical analysis of infarction in pituitary adenoma. , 2015, International journal of clinical and experimental medicine.

[11]  E. Oldfield,et al.  Apoplexy of pituitary adenomas: the perfect storm. , 2015, Journal of neurosurgery.

[12]  P. Chanson,et al.  Pituitary Apoplexy. , 2015, Endocrine reviews.

[13]  G. Vargas,et al.  Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case-control study. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[14]  K. Sugiyama,et al.  Impact of subclinical haemorrhage on the pituitary gland in patients with pituitary adenomas , 2014, Clinical endocrinology.

[15]  C. Daousi,et al.  Presentation, management and outcomes in acute pituitary apoplexy: a large single‐centre experience from the United Kingdom , 2010, Clinical endocrinology.

[16]  P. Carroll,et al.  The prevalence and natural history of pituitary hemorrhage in prolactinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[17]  James V. Byrne,et al.  Pituitary apoplexy in non‐functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences , 2011, Clinical endocrinology.

[18]  C. Kim,et al.  Visual outcome after transsphenoidal surgery in patients with pituitary apoplexy. , 2011, Journal of Korean Neurosurgical Society.

[19]  G. Plant,et al.  UK guidelines for the management of pituitary apoplexy , 2011, Clinical endocrinology.

[20]  H. Dufour,et al.  A conservative management is preferable in milder forms of pituitary tumor apoplexy , 2010, Journal of endocrinological investigation.

[21]  R. Bernays,et al.  Pituitary apoplexy: re-evaluation of risk factors for bleeding into pituitary adenomas and impact on outcome. , 2011, European journal of endocrinology.

[22]  Sung-Kyoo Hwang,et al.  Clinical outcome of cranial neuropathy in patients with pituitary apoplexy. , 2010, Journal of Korean Neurosurgical Society.

[23]  K. Wei,et al.  Clinical features and surgical outcome of clinical and subclinical pituitary apoplexy , 2010, Journal of Clinical Neuroscience.

[24]  M. Turgut,et al.  Pituitary apoplexy: an overview of 186 cases published during the last century , 2010, Acta Neurochirurgica.

[25]  E. Eggenberger,et al.  Pituitary apoplexy: evaluation, management, and prognosis , 2009, Current opinion in ophthalmology.

[26]  Juxiang Chen,et al.  Manifestation, management and outcome of subclinical pituitary adenoma apoplexy , 2009, Journal of Clinical Neuroscience.

[27]  J. Kim,et al.  Pituitary Apoplexy due to Pituitary Adenoma Infarction. , 2008, Journal of Korean Neurosurgical Society.

[28]  E. Laws,et al.  Pituitary apoplexy: correlation between magnetic resonance imaging and histopathological results. , 2008, Journal of neurosurgery.

[29]  A. Beckers,et al.  Classical pituitary tumour apoplexy: Clinical features, management and outcomes in a series of 24 patients , 2007, Clinical Neurology and Neurosurgery.

[30]  W. Couldwell,et al.  Pituitary apoplexy in the magnetic resonance imaging era: clinical significance of sphenoid sinus mucosal thickening. , 2006, Journal of neurosurgery.

[31]  K. Sugiyama,et al.  Natural course of incidentally found nonfunctioning pituitary adenoma, with special reference to pituitary apoplexy during follow-up examination. , 2006, Journal of neurosurgery.

[32]  E. Laws,et al.  Pituitary apoplexy: do histological features influence the clinical presentation and outcome? , 2006, Journal of neurosurgery.

[33]  P. Mansell,et al.  Pituitary apoplexy: retrospective review of 30 patients—is surgical intervention always necessary? , 2005, British journal of neurosurgery.

[34]  V. Lazarevic,et al.  Spontaneous remission of , 2006 .

[35]  Z. Rumboldt Pituitary Adenomas , 2005, Topics in magnetic resonance imaging : TMRI.

[36]  N. de Tribolet,et al.  Apoplexy in Pituitary Macroadenoma: Eight Patients Presenting in 12 Months , 2005, Medicine.

[37]  T. Miki,et al.  Spontaneous remission of functioning pituitary adenomas without hypopituitarism following infarctive apoplexy: two case reports. , 2005, Endocrine journal.

[38]  R. Quinton,et al.  Pituitary Apoplexy: A Review of Clinical Presentation, Management and Outcome in 45 Cases , 2005, Pituitary.

[39]  W. Zgliczyński,et al.  Pituitary apoplexy: Endocrine, surgical and oncological emergency. Incidence, clinical course and treatment with reference to 799 cases of pituitary adenomas , 2005, Acta Neurochirurgica.

[40]  R. Mitchell,et al.  Acute management of pituitary apoplexy – surgery or conservative management? , 2004, Clinical endocrinology.

[41]  W. Selman,et al.  Pituitary tumor apoplexy: characteristics, treatment, and outcomes. , 2004, Neurosurgical focus.

[42]  A. Chacko,et al.  Hemorrhagic necrosis of pituitary adenomas. , 2002, Neurology India.

[43]  G. Tung,et al.  Pituitary apoplexy: early detection with diffusion-weighted MR imaging. , 2002, AJNR. American journal of neuroradiology.

[44]  H. Turner Pituitary Tumor Angiogenesis , 2001 .

[45]  N. Newman,et al.  Precipitating factors in pituitary apoplexy , 2001, Journal of neurology, neurosurgery, and psychiatry.

[46]  H. Randeva,et al.  Classical pituitary apoplexy: clinical features, management and outcome , 1999, Clinical endocrinology.

[47]  D. Cm,et al.  Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. , 1999 .

[48]  P. D. de Mello,et al.  Pituitary apoplexy. Clinical course, endocrine evaluations and treatment analysis. , 1999, Journal of neurosurgical sciences.

[49]  K. Lillehei,et al.  Pathological correlates of pituitary adenomas presenting with apoplexy. , 1998, Human pathology.

[50]  M. Kayath,et al.  Conservative management of pituitary apoplexy: a prospective study. , 1995, The Journal of clinical endocrinology and metabolism.

[51]  B. Scheithauer,et al.  Vasculature in nontumorous hypophyses, pituitary adenomas, and carcinomas: A quantitative morphologic study , 1995, Endocrine pathology.

[52]  B. Scheithauer,et al.  A retrospective analysis of pituitary apoplexy. , 1993, Neurosurgery.

[53]  G. Teasdale,et al.  Pituitary apoplexy and its effect on vision. , 1991, Neurosurgery.

[54]  V. Esposito,et al.  Hemorrhagic pituitary adenomas: clinicopathological features and surgical treatment. , 1990, Neurosurgery.

[55]  W. Selman,et al.  Improvement of pituitary function after surgical decompression for pituitary tumor apoplexy. , 1990, The Journal of clinical endocrinology and metabolism.

[56]  T. Wisniewski,et al.  Clinical versus subclinical pituitary apoplexy: presentation, surgical management, and outcome in 21 patients. , 1990, Neurosurgery.

[57]  S. Wakai,et al.  Pituitary apoplexy: its incidence and clinical significance. , 1981, Journal of neurosurgery.

[58]  J. Fein,et al.  Pituitary apoplexy: a review and reappraisal. , 1972, Journal of neurosurgery.

[59]  J Otradovec,et al.  [Pituitary apoplexy]. , 1972, Ceskoslovenska oftalmologie.

[60]  F. J. Nattrass Apoplexy , 1953, The Medical officer.